Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Miriam Olivola

Dados Biográficos

ID7656754
NOMEMiriam Olivola
PRENOMESMiriam
SOBRENOMEOlivola
ASSINATURAOLIVOLA M
AFILIAÇÕESUniversity of Pavia
ORCID0000-0003-0914-0539
VERIFICADOSim
TOTAL DE OBRAS4
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2022
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0
  • Personalizing esketamine treatment in TRD and TRBD

    Open Access•Miriam Olivola, Filippo Mazzoni et al.•ARTICLE•Frontiers in Psychiatry•2026

    These findings highlight the importance of a personalized treatment approach in treatment- resistant depressive episode patients. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals w…

  • Efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD

    Open Access•Vassilis Martiadis, Enrico Pessina et al.•ARTICLE•Frontiers in Psychiatry•2025

    This study provides preliminary evidence of the efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD. The observed improvements in OCD, depressive and anxiety symptoms suggest that vortioxetine may represent a valuable therapeutic option. Further prospective controlled trials are needed to confirm these findings

  • Risk factors for suicidal attempts in a sample of outpatients with treatment-resistant depression

    Open Access•Serena Chiara Civardi, Filippo Besana et al.•ARTICLE•Frontiers in Psychiatry•2024

    The integrated treatment of comorbidities and substance abuse, which involves different mental health services, is fundamental in achieving the recovery of these patients. Our study supports the importance of performing a careful clinical evaluation of patients with TRD in order to identify factors associated with increased risk of suicide attempts

  • Age at onset of mental disorders worldwide

    Open Access•Marco Solmi, Joaquim Radua et al.•ARTICLE•Molecular Psychiatry•2022

    Promotion of good mental health, prevention, and early intervention before/at the onset of mental disorders improve outcomes. However, the range and peak ages at onset for mental disorders are not fully established. To provide robust, global epidemiological estimates of age at onset for mental disorders, we conducted a PRISMA/MOOSE-compliant systematic review with meta-analysis of birth cohort/cross-sectional/cohort studies, representative of the…

Sem obras proeminentes nesta página.

  • Age at onset of mental disorders worldwide

    Open Access•Marco Solmi, Joaquim Radua et al.•ARTICLE•Molecular Psychiatry•2022

    Promotion of good mental health, prevention, and early intervention before/at the onset of mental disorders improve outcomes. However, the range and peak ages at onset for mental disorders are not fully established. To provide robust, global epidemiological estimates of age at onset for mental disorders, we conducted a PRISMA/MOOSE-compliant systematic review with meta-analysis of birth cohort/cross-sectional/cohort studies, representative of the…

  • Risk factors for suicidal attempts in a sample of outpatients with treatment-resistant depression

    Open Access•Serena Chiara Civardi, Filippo Besana et al.•ARTICLE•Frontiers in Psychiatry•2024

    The integrated treatment of comorbidities and substance abuse, which involves different mental health services, is fundamental in achieving the recovery of these patients. Our study supports the importance of performing a careful clinical evaluation of patients with TRD in order to identify factors associated with increased risk of suicide attempts

  • Efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD

    Open Access•Vassilis Martiadis, Enrico Pessina et al.•ARTICLE•Frontiers in Psychiatry•2025

    This study provides preliminary evidence of the efficacy and tolerability of vortioxetine monotherapy in SSRI-resistant OCD. The observed improvements in OCD, depressive and anxiety symptoms suggest that vortioxetine may represent a valuable therapeutic option. Further prospective controlled trials are needed to confirm these findings

  • Personalizing esketamine treatment in TRD and TRBD

    Open Access•Miriam Olivola, Filippo Mazzoni et al.•ARTICLE•Frontiers in Psychiatry•2026

    These findings highlight the importance of a personalized treatment approach in treatment- resistant depressive episode patients. Esketamine may be particularly beneficial in reducing cognitive rigidity, improving mentalization, and breaking the cognitive inflexibility that contributes to sustained negative depressive thinking patterns. Further research is needed to refine patient stratification and optimize treatment strategies for individuals w…

Major depressive disorder (3 obras) · Antidepressant (2 obras) · Anxiety (2 obras) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 obras) · Depression (economics (2 obras) · Internal Medicine (2 obras) · Medicine (2 obras) · Psychiatry (2 obras) · Treatment of Major Depression (2 obras) · Adverse effect (1 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae